Immediate Impact
2 from Science/Nature 66 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
2024 Standout
Works of Qiufeng He being referenced
Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Qiufeng He | 92 | 79 | 95 | 148 | 99 | 19 | 511 | |
| Andrew George | 50 | 87 | 85 | 90 | 86 | 36 | 567 | |
| Omar Racchi | 57 | 47 | 83 | 105 | 75 | 19 | 456 | |
| Emer O’Connell | 145 | 88 | 54 | 233 | 55 | 35 | 489 | |
| Rajani Kaimal | 68 | 39 | 85 | 177 | 64 | 15 | 442 | |
| Alessandro Iaculli | 41 | 71 | 80 | 228 | 45 | 14 | 470 | |
| Caterina Mancusi | 50 | 56 | 100 | 112 | 64 | 21 | 495 | |
| Concetta Anna Dodaro | 125 | 103 | 68 | 136 | 33 | 38 | 564 | |
| Ruonan Yang | 88 | 95 | 80 | 260 | 48 | 16 | 502 | |
| Xiaobei Chen | 33 | 60 | 54 | 158 | 58 | 20 | 504 | |
| Carolin Pütter | 59 | 36 | 54 | 61 | 50 | 25 | 417 |
All Works
Login with ORCID to disown or claim papers
Loading papers...